Latest Bapineuzumab Stories

2012-08-07 20:35:06

Michael Harper for redOrbit.com - Your Universe Online After another failed high-profile clinical trial, pharmaceutical companies Pfiizer Inc and Johnson & Johnson have said they´ve halted research and development of bapineuzumab, a drug which could have been used in patients with mild to moderate Alzheimer's disease. According to Reuters, both drug makers have said they´ll discontinue their studies of bapineuzumab in its intravenous (IV) form. Two late stage trials and...

2012-07-31 10:33:19

An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer's disease. The findings, published July 31, 2012 in Molecular Psychiatry, demonstrate renewed potential for this compound and could lead to clinical trials in patients...

Pfizer Drug Study Falls Short For Alzheimer’s
2012-07-24 08:50:54

Lawrence LeBlond for redOrbit.com - Your Universe Online In one of two late-stage trials conducted by Pfizer, an experimental Alzheimer´s drug failed to slow the disease´s progress, but the pharma said on Monday that it will continue to study the drug´s effect on the other group. The injected drug bapineuzumab, being tested through a partnership with Johnson & Johnson, didn´t slow mental or functional decline in patients with mild or moderate Alzheimer´s...

2012-04-03 08:47:33

Immunotherapy with the antibody bapineuzumab in patients with mild to moderate Alzheimer disease resulted in decreases in a cerebrospinal fluid biomarker, which may indicate downstream effects on the degenerative process, according to a report published Online First by Archives of Neurology, a JAMA Network publication. Alzheimer disease (AD) is a progressive neurodegenerative disease characterized by, among other things, deposits of extracellular β-amyloid (Αβ)...

Word of the Day
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.